Rapid Micro Biosystems, Inc. (RPID) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	35.2M	33.6M	28.1M	22.5M	17.1M
Cost of Revenue	31.6M	26.0M	28.2M	28.0M	25.7M
Gross Profit	3.5M	7.6M	(109.0K)	(5.5M)	(8.5M)
Operating Expenses
R&D Expense	13.4M	13.6M	14.6M	12.8M	12.9M
SG&A Expense	38.3M	34.8M	35.2M	38.3M	41.8M
General & Admin Expense	25.2M	22.8M	21.9M	24.9M	26.8M
Selling & Marketing Expense	13.1M	12.1M	13.3M	13.3M	15.0M
Other Expenses	1.6M	6.6M	—	—	—
Total Operating Expenses	53.3M	55.0M	49.8M	51.1M	54.7M
Cost and Expenses	84.9M	81.0M	78.0M	79.1M	80.4M
Operating Income (EBIT)	(49.8M)	(47.4M)	(49.9M)	(56.6M)	(63.2M)
Non-Operating
Interest Income	1.2M	1.5M	3.2M	4.2M	1.8M
Interest Expense	2.5M	1.1M	—	—	—
Net Interest Income	(1.3M)	419.0K	3.2M	4.2M	1.8M
Other Non-Op Income/Expense	(1.4M)	309.0K	3.1M	4.1M	1.8M
Non-Operating Income (excl Interest)	(1.1M)	(1.4M)	(3.1M)	(4.1M)	(1.8M)
EBT (Pre-Tax Income)	(51.1M)	(47.1M)	(46.9M)	(52.4M)	(61.4M)
Income Tax Expense	75.0K	40.0K	22.0K	31.0K	(576.0K)
Bottom Line
Net Income	(51.2M)	(47.1M)	(46.9M)	(52.5M)	(60.8M)
Earnings from Cont. Ops	(51.2M)	(47.1M)	(46.9M)	(52.5M)	(60.8M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(51.2M)	(47.1M)	(46.9M)	(52.5M)	(60.8M)
Per Share
Basic EPS	($1.11)	($1.05)	($1.08)	($1.22)	($1.43)
Diluted EPS	($1.11)	($1.05)	($1.08)	($1.22)	($1.43)
Revenue Per Share	$0.75	$0.75	$0.64	$0.52	$0.40
Shares
Basic Shares Outstanding	47.0M	44.7M	43.6M	43.0M	42.5M
Diluted Shares Outstanding	47.0M	44.7M	43.6M	43.0M	42.5M
Profitability Metrics
EBITDA	(46.3M)	(42.7M)	(43.5M)	(49.3M)	(58.5M)
D&A	2.3M	3.3M	3.4M	3.1M	2.8M
EBIT	(48.6M)	(46.0M)	(46.9M)	(52.4M)	(61.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026